Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis

Background: Pentraxin3 (PTX3) is overexpressed in kidneys of patients developing lupus nephritis (LN). Active LN is associated with reduced anti-PTX3 antibodies. However, abnormalities of B cell differentiation against PTX3 have not been characterized in systemic lupus erythematosus (SLE).Objective:...

Full description

Bibliographic Details
Main Authors: Mariele Gatto, Annika Wiedemann, Nadja Nomovi, Karin Reiter, Eva Schrezenmeier, Thomas Rose, Franziska Szelinski, Andreia C. Lino, Sonia Valentino, Anna Ghirardello, Thomas Dörner, Andrea Doria
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.00029/full
_version_ 1828769462432563200
author Mariele Gatto
Mariele Gatto
Annika Wiedemann
Nadja Nomovi
Karin Reiter
Eva Schrezenmeier
Thomas Rose
Franziska Szelinski
Andreia C. Lino
Sonia Valentino
Anna Ghirardello
Thomas Dörner
Andrea Doria
author_facet Mariele Gatto
Mariele Gatto
Annika Wiedemann
Nadja Nomovi
Karin Reiter
Eva Schrezenmeier
Thomas Rose
Franziska Szelinski
Andreia C. Lino
Sonia Valentino
Anna Ghirardello
Thomas Dörner
Andrea Doria
author_sort Mariele Gatto
collection DOAJ
description Background: Pentraxin3 (PTX3) is overexpressed in kidneys of patients developing lupus nephritis (LN). Active LN is associated with reduced anti-PTX3 antibodies. However, abnormalities of B cell differentiation against PTX3 have not been characterized in systemic lupus erythematosus (SLE).Objective: Characterization of PTX3-specific (PTX3+) B cells in peripheral blood of SLE patients with or without LN and healthy donors (HD).Patients and Methods: SLE patients without LN, biopsy-proven LN and matched HD were analyzed. Active LN was defined as proteinuria>0.5 g/day or CrCl<60 ml/min/1.73 m2 with active urinary sediment. Peripheral B cells were analyzed for direct PTX3 binding by flow cytometry using PTX3 labeled with cyanine 5 (Cy5) and phycoerythrin (PE).Results: Initially, a flow cytometry based assay to identify PTX3+ B cells was developed by demonstrating simultaneous binding of PTX3-Cy5 and PTX3-PE. Specificity of B cells was validated by blocking experiments using unlabeled PTX3. We could identify circulating PTX3+ B-cells in HD and patients. Notably, LN patients showed a significantly diminished number of PTX3+ B cells (SLE vs. LN p = 0.033; HD vs. LN p = 0.008). This decrease was identified in naïve and memory B cell compartments (naïve: SLE vs. LN p = 0.028; HD vs. LN p = 0.0001; memory: SLE vs. LN p = 0.038, HD vs. LN p = 0.011).Conclusions: Decreased PTX3+ B cells in LN within the naïve and memory compartment suggest their negative selection at early stages of B cell development potentially related to a decreased regulatory function. PTX3+ B cells could candidate for autoantigen-defined regulatory B cells as a striking abnormality of LN patients.
first_indexed 2024-12-11T13:48:32Z
format Article
id doaj.art-9cf005332572471abdd500599e8ffda5
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T13:48:32Z
publishDate 2019-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-9cf005332572471abdd500599e8ffda52022-12-22T01:04:22ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-01-011010.3389/fimmu.2019.00029428457Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus NephritisMariele Gatto0Mariele Gatto1Annika Wiedemann2Nadja Nomovi3Karin Reiter4Eva Schrezenmeier5Thomas Rose6Franziska Szelinski7Andreia C. Lino8Sonia Valentino9Anna Ghirardello10Thomas Dörner11Andrea Doria12Unit of Rheumatology, Department of Medicine, University of Padova, Padua, ItalyDepartment Medicine, Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, GermanyDepartment Medicine, Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, GermanyDepartment Medicine, Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, GermanyDepartment Medicine, Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, GermanyDepartment of Medicine, Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Berlin, GermanyDepartment Medicine, Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, GermanyDepartment Medicine, Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, GermanyDeutsches Rheuma-Forschungszentrum (DRFZ), Berlin, GermanyHumanitas Clinical and Research Center, Milan, ItalyUnit of Rheumatology, Department of Medicine, University of Padova, Padua, ItalyDepartment Medicine, Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, GermanyUnit of Rheumatology, Department of Medicine, University of Padova, Padua, ItalyBackground: Pentraxin3 (PTX3) is overexpressed in kidneys of patients developing lupus nephritis (LN). Active LN is associated with reduced anti-PTX3 antibodies. However, abnormalities of B cell differentiation against PTX3 have not been characterized in systemic lupus erythematosus (SLE).Objective: Characterization of PTX3-specific (PTX3+) B cells in peripheral blood of SLE patients with or without LN and healthy donors (HD).Patients and Methods: SLE patients without LN, biopsy-proven LN and matched HD were analyzed. Active LN was defined as proteinuria>0.5 g/day or CrCl<60 ml/min/1.73 m2 with active urinary sediment. Peripheral B cells were analyzed for direct PTX3 binding by flow cytometry using PTX3 labeled with cyanine 5 (Cy5) and phycoerythrin (PE).Results: Initially, a flow cytometry based assay to identify PTX3+ B cells was developed by demonstrating simultaneous binding of PTX3-Cy5 and PTX3-PE. Specificity of B cells was validated by blocking experiments using unlabeled PTX3. We could identify circulating PTX3+ B-cells in HD and patients. Notably, LN patients showed a significantly diminished number of PTX3+ B cells (SLE vs. LN p = 0.033; HD vs. LN p = 0.008). This decrease was identified in naïve and memory B cell compartments (naïve: SLE vs. LN p = 0.028; HD vs. LN p = 0.0001; memory: SLE vs. LN p = 0.038, HD vs. LN p = 0.011).Conclusions: Decreased PTX3+ B cells in LN within the naïve and memory compartment suggest their negative selection at early stages of B cell development potentially related to a decreased regulatory function. PTX3+ B cells could candidate for autoantigen-defined regulatory B cells as a striking abnormality of LN patients.https://www.frontiersin.org/article/10.3389/fimmu.2019.00029/fullSLEPTX3+ B cellslupus nephritisbiomarkersflow-cytometry
spellingShingle Mariele Gatto
Mariele Gatto
Annika Wiedemann
Nadja Nomovi
Karin Reiter
Eva Schrezenmeier
Thomas Rose
Franziska Szelinski
Andreia C. Lino
Sonia Valentino
Anna Ghirardello
Thomas Dörner
Andrea Doria
Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
Frontiers in Immunology
SLE
PTX3+ B cells
lupus nephritis
biomarkers
flow-cytometry
title Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
title_full Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
title_fullStr Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
title_full_unstemmed Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
title_short Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
title_sort circulating pentraxin3 specific b cells are decreased in lupus nephritis
topic SLE
PTX3+ B cells
lupus nephritis
biomarkers
flow-cytometry
url https://www.frontiersin.org/article/10.3389/fimmu.2019.00029/full
work_keys_str_mv AT marielegatto circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT marielegatto circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT annikawiedemann circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT nadjanomovi circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT karinreiter circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT evaschrezenmeier circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT thomasrose circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT franziskaszelinski circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT andreiaclino circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT soniavalentino circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT annaghirardello circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT thomasdorner circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis
AT andreadoria circulatingpentraxin3specificbcellsaredecreasedinlupusnephritis